HYPR
Hyperfine, Inc.
Price Chart
Latest Quote
$1.46
-0.01 (-0.68%)
Current Price
| Previous Close | $1.47 |
| Open | $1.47 |
| Day High | $1.48 |
| Day Low | $1.41 |
| Volume | 557,035 |
Stock Information
| Shares Outstanding | 84.22M |
| Total Debt | $13.37M |
| Cash Equivalents | $40.78M |
| Revenue | $15.33M |
| Net Income | $-34.78M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $144.93M |
| EPS (TTM) | $-0.40 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $117.53M |
| Sales | $15.33M |
| Income | $-34.78M |
| Book/sh | $0.35 |
| Cash/sh | $0.48 |
| Employees | 102 |
Financial Ratios
| Quick Ratio | 4.59 |
| Current Ratio | 5.52 |
| Debt/Eq | 38.91 |
Returns & Margins
| ROA | -38.19% |
| ROE | -89.78% |
| Gross Margin | 51.20% |
| Operating Margin | -219.27% |
| Profit Margin | -226.88% |
Ownership
| Insider Ownership | 4.81% |
| Institutional Ownership | 14.67% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -4.29 |
| P/S | 9.45 |
| P/B | 4.18 |
Analyst Data
| Recommendation | none |
| Target Price | $2.17 |
Technical Indicators
| SMA20 | $1.47 |
| SMA50 | $1.49 |
| SMA200 | $1.27 |
| RSI | 47.69 |
| ATR | 0.1039 |
| Shares Float | 79.64M |
| Short Float | 1.98% |
| Short Ratio | 1.96 |
| Volatility | 1.39 |
| Rel Volume | 0.76 |
Performance History
| Week | +5.80% |
| Month | -2.01% |
| Quarter | +26.96% |
| 6 Months | +32.73% |
| YTD | +50.67% |
| Year | +110.37% |
| 3 Years | -30.48% |
| 5 Years | -85.03% |
| 10 Years | -85.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.46 | 557,300 |
| 2026-06-23 | $1.47 | 610,500 |
| 2026-06-22 | $1.49 | 1,723,100 |
| 2026-06-18 | $1.60 | 4,031,100 |
| 2026-06-17 | $1.39 | 414,400 |
| 2026-06-16 | $1.38 | 479,800 |
| 2026-06-15 | $1.38 | 359,700 |
| 2026-06-12 | $1.36 | 464,100 |
| 2026-06-11 | $1.42 | 310,600 |
| 2026-06-10 | $1.40 | 443,300 |
| 2026-06-09 | $1.42 | 533,100 |
| 2026-06-08 | $1.41 | 413,100 |
| 2026-06-05 | $1.38 | 424,600 |
| 2026-06-04 | $1.50 | 613,700 |
| 2026-06-03 | $1.49 | 475,000 |
| 2026-06-02 | $1.50 | 575,600 |
| 2026-06-01 | $1.52 | 304,600 |
| 2026-05-29 | $1.56 | 711,000 |
| 2026-05-28 | $1.60 | 424,500 |
| 2026-05-27 | $1.59 | 735,400 |
| 2026-05-26 | $1.66 | 1,525,900 |
About Hyperfine, Inc.
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
đ° Latest News
Hyperfine shares rise after expected Russell index addition (HYPR)
InvestorsHub âĸ 2026-05-26T12:57:25Z
Hyperfine Inc (HYPR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ...
GuruFocus.com âĸ 2026-05-13T05:01:28ZHyperfine Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T00:25:02Z
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-12T21:40:04Z
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-11T22:05:04Z
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-08T12:25:03Z
BTIG Initiates Coverage of Hyperfine, Inc. (HYPR) With a Bullish Outlook
Insider Monkey âĸ 2026-05-07T17:29:19Z
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
Zacks âĸ 2026-05-01T13:45:01Z
Forget Neuralink: The Real Brain Tech Trade Has 10 Names Youâve Never Heard
InvestorPlace âĸ 2026-04-25T14:05:00ZHyperfine receives $40m from Horizon for Swoop System expansion
Medical Device Network âĸ 2026-03-24T12:01:29Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,810,000 | $6,999,000 | $6,275,000 | $5,907,000 |
| Cost Of Revenue | $6,810,000 | $6,999,000 | $6,275,000 | $5,907,000 |
| Total Revenue | $13,563,000 | $12,890,000 | $11,032,000 | $6,814,000 |
| Operating Revenue | $13,563,000 | $12,890,000 | $11,032,000 | $6,814,000 |
| Expenses | ||||
| Total Expenses | $50,648,000 | $56,114,000 | $59,147,000 | $80,688,000 |
| Other Income Expense | $488,000 | $12,000 | $35,000 | $-51,000 |
| Other Non Operating Income Expenses | $-337,000 | $12,000 | $35,000 | $-51,000 |
| Net Non Operating Interest Income Expense | $1,023,000 | $2,492,000 | $3,842,000 | $761,000 |
| Operating Expense | $43,838,000 | $49,115,000 | $52,872,000 | $74,781,000 |
| Selling And Marketing Expense | $10,134,000 | $9,122,000 | $10,103,000 | $14,219,000 |
| General And Administrative Expense | $16,253,000 | $17,494,000 | $20,276,000 | $32,406,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Net Interest Income | $1,023,000 | $2,492,000 | $3,842,000 | $761,000 |
| Interest Income | $1,023,000 | $2,492,000 | $3,842,000 | $761,000 |
| Normalized Income | $-36,399,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Net Income From Continuing And Discontinued Operation | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Total Operating Income As Reported | $-37,085,000 | $-43,224,000 | $-48,115,000 | $-73,874,000 |
| Net Income Common Stockholders | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Net Income | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Net Income Including Noncontrolling Interests | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Net Income Continuous Operations | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Pretax Income | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Interest Income Non Operating | $1,023,000 | $2,492,000 | $3,842,000 | $761,000 |
| Operating Income | $-37,085,000 | $-43,224,000 | $-48,115,000 | $-73,874,000 |
| Gross Profit | $6,753,000 | $5,891,000 | $4,757,000 | $907,000 |
| Per Share | ||||
| Diluted EPS | $-0.43 | $-0.56 | $-0.62 | $-1.04 |
| Basic EPS | $-0.43 | $-0.56 | $-0.62 | $-1.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-36,820,000 | $-42,215,000 | $-47,061,000 | $-72,859,000 |
| Total Unusual Items | $825,000 | - | - | - |
| Total Unusual Items Excluding Goodwill | $825,000 | - | - | - |
| Reconciled Depreciation | $1,090,000 | $1,009,000 | $1,054,000 | $1,015,000 |
| EBITDA (Bullshit earnings) | $-35,995,000 | $-42,215,000 | $-47,061,000 | $-72,859,000 |
| EBIT | $-37,085,000 | $-43,224,000 | $-48,115,000 | $-73,874,000 |
| Diluted Average Shares | $81,795,105 | $72,413,541 | $71,316,424 | $70,449,191 |
| Basic Average Shares | $81,795,105 | $72,413,541 | $71,316,424 | $70,449,191 |
| Diluted NI Availto Com Stockholders | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $825,000 | - | - | - |
| Research And Development | $17,451,000 | $22,499,000 | $22,493,000 | $28,156,000 |
| Selling General And Administration | $26,387,000 | $26,616,000 | $30,379,000 | $46,625,000 |
| Other Gand A | $16,253,000 | $17,494,000 | $20,276,000 | $32,406,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Total Assets | $55,262,000 | $58,901,000 | $94,199,000 | $134,051,000 |
| Total Non Current Assets | $4,353,000 | $5,191,000 | $5,291,000 | $5,387,000 |
| Other Non Current Assets | $1,804,000 | $2,069,000 | $2,292,000 | $2,139,000 |
| Current Assets | $50,909,000 | $53,710,000 | $88,908,000 | $128,664,000 |
| Other Current Assets | $1,255,000 | $1,900,000 | $2,391,000 | $3,194,000 |
| Restricted Cash | $957,000 | $28,000 | $621,000 | $771,000 |
| Inventory | $7,090,000 | $5,832,000 | $6,582,000 | $4,622,000 |
| Receivables | $6,522,000 | $8,305,000 | $4,131,000 | $2,605,000 |
| Other Receivables | $1,268,000 | $2,349,000 | $942,000 | $454,000 |
| Accounts Receivable | $5,254,000 | $5,956,000 | $3,189,000 | $2,103,000 |
| Allowance For Doubtful Accounts Receivable | $-1,372,000 | $-651,000 | $-321,000 | $-180,000 |
| Gross Accounts Receivable | $6,626,000 | $6,607,000 | $3,510,000 | $2,283,000 |
| Cash Cash Equivalents And Short Term Investments | $35,085,000 | $37,645,000 | $75,183,000 | $117,472,000 |
| Cash And Cash Equivalents | $35,085,000 | $37,645,000 | $75,183,000 | $117,472,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $248,000 | $269,000 | $185,000 | $0 |
| Current Debt And Capital Lease Obligation | $248,000 | $269,000 | $185,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,257,000 | $9,861,000 | $9,800,000 | $10,329,000 |
| Total Non Current Liabilities Net Minority Interest | $2,525,000 | $1,132,000 | $1,032,000 | $1,526,000 |
| Other Non Current Liabilities | $66,000 | $78,000 | $64,000 | - |
| Derivative Product Liabilities | $1,730,000 | $0 | - | - |
| Non Current Deferred Liabilities | $729,000 | $1,054,000 | $968,000 | $1,526,000 |
| Current Liabilities | $11,732,000 | $8,729,000 | $8,768,000 | $8,803,000 |
| Other Current Liabilities | $460,000 | $473,000 | $446,000 | $38,000 |
| Current Deferred Liabilities | $2,501,000 | $1,488,000 | $2,074,000 | $2,149,000 |
| Payables And Accrued Expenses | $6,055,000 | $4,355,000 | $3,600,000 | $3,942,000 |
| Payables | $4,101,000 | $1,668,000 | $1,275,000 | $678,000 |
| Accounts Payable | $4,051,000 | $1,607,000 | $1,214,000 | $678,000 |
| Equity | ||||
| Common Stock Equity | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Total Equity Gross Minority Interest | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Stockholders Equity | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Retained Earnings | $-330,016,000 | $-294,442,000 | $-253,722,000 | $-209,484,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $97,221,746 | $73,131,549 | $71,896,237 | $70,677,776 |
| Share Issued | $97,221,746 | $73,131,549 | $71,896,237 | $70,677,776 |
| Tangible Book Value | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Invested Capital | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Working Capital | $39,177,000 | $44,981,000 | $80,140,000 | $119,861,000 |
| Capital Lease Obligations | $248,000 | $269,000 | $185,000 | $0 |
| Total Capitalization | $41,005,000 | $49,040,000 | $84,399,000 | $123,722,000 |
| Additional Paid In Capital | $371,011,000 | $343,475,000 | $338,114,000 | $333,199,000 |
| Capital Stock | $10,000 | $7,000 | $7,000 | $7,000 |
| Common Stock | $10,000 | $7,000 | $7,000 | $7,000 |
| Non Current Deferred Revenue | $729,000 | $1,054,000 | $968,000 | $1,526,000 |
| Current Deferred Revenue | $2,501,000 | $1,488,000 | $2,074,000 | $2,149,000 |
| Current Capital Lease Obligation | $248,000 | $269,000 | $185,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,468,000 | $2,144,000 | $2,463,000 | $2,674,000 |
| Current Accrued Expenses | $1,954,000 | $2,687,000 | $2,325,000 | $3,264,000 |
| Dueto Related Parties Current | $50,000 | $61,000 | $61,000 | $0 |
| Net PPE | $2,549,000 | $3,122,000 | $2,999,000 | $3,248,000 |
| Accumulated Depreciation | $-4,444,000 | $-3,557,000 | $-3,039,000 | $-2,322,000 |
| Gross PPE | $6,993,000 | $6,679,000 | $6,038,000 | $5,570,000 |
| Construction In Progress | $383,000 | $1,229,000 | $595,000 | $359,000 |
| Other Properties | $5,921,000 | $4,761,000 | $4,775,000 | $4,588,000 |
| Machinery Furniture Equipment | $689,000 | $689,000 | $668,000 | $623,000 |
| Finished Goods | $4,154,000 | $2,762,000 | $4,825,000 | $2,381,000 |
| Raw Materials | $2,936,000 | $3,070,000 | $1,757,000 | $2,241,000 |
| Duefrom Related Parties Current | - | - | $0 | $48,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-29,133,000 | $-39,150,000 | $-42,613,000 | $-72,924,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-27,948,000 | $-38,767,000 | $-41,809,000 | $-72,339,000 |
| Cash Flow From Continuing Operating Activities | $-27,948,000 | $-38,767,000 | $-41,809,000 | $-72,339,000 |
| Operating Gains Losses | $-825,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,185,000 | $-383,000 | $-804,000 | $-585,000 |
| Investing Cash Flow | $-1,185,000 | $-383,000 | $-804,000 | $-585,000 |
| Cash Flow From Continuing Investing Activities | $-1,185,000 | $-383,000 | $-804,000 | $-585,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $27,009,000 | $848,000 | $0 | $0 |
| Financing Cash Flow | $27,502,000 | $1,019,000 | $174,000 | $7,000 |
| Cash Flow From Continuing Financing Activities | $27,502,000 | $1,019,000 | $174,000 | $7,000 |
| Net Common Stock Issuance | $27,009,000 | $848,000 | $0 | - |
| Common Stock Issuance | $27,009,000 | $848,000 | $0 | - |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| End Cash Position | $36,042,000 | $37,673,000 | $75,804,000 | $118,243,000 |
| Beginning Cash Position | $37,673,000 | $75,804,000 | $118,243,000 | $191,160,000 |
| Changes In Cash | $-1,631,000 | $-38,131,000 | $-42,439,000 | $-72,917,000 |
| Proceeds From Stock Option Exercised | $493,000 | $171,000 | $174,000 | $7,000 |
| Net PPE Purchase And Sale | $-1,185,000 | $-383,000 | $-804,000 | $-585,000 |
| Purchase Of PPE | $-1,185,000 | $-383,000 | $-804,000 | $-585,000 |
| Change In Working Capital | $4,412,000 | $-3,622,000 | $-3,615,000 | $-10,933,000 |
| Change In Other Working Capital | $688,000 | $-500,000 | $-606,000 | $-227,000 |
| Change In Other Current Liabilities | $-8,000 | $-5,000 | $10,000 | $0 |
| Change In Other Current Assets | $240,000 | $325,000 | $-220,000 | $-632,000 |
| Change In Payables And Accrued Expense | $2,748,000 | $-301,000 | $-148,000 | $-5,697,000 |
| Change In Accrued Expense | $332,000 | $-683,000 | $-742,000 | $-2,146,000 |
| Change In Payable | $2,416,000 | $382,000 | $594,000 | $-3,551,000 |
| Change In Account Payable | $2,427,000 | $382,000 | $533,000 | $-1,570,000 |
| Change In Prepaid Assets | $436,000 | $471,000 | $1,084,000 | $-2,118,000 |
| Change In Inventory | $-1,475,000 | $562,000 | $-2,209,000 | $-312,000 |
| Change In Receivables | $1,783,000 | $-4,174,000 | $-1,526,000 | $-1,947,000 |
| Changes In Account Receivables | $702,000 | $-2,767,000 | $-1,086,000 | $-1,550,000 |
| Other Non Cash Items | $27,000 | $-11,000 | $25,000 | $91,000 |
| Stock Based Compensation | $2,801,000 | $4,362,000 | $4,741,000 | $10,652,000 |
| Asset Impairment Charge | $121,000 | $215,000 | $224,000 | $0 |
| Depreciation Amortization Depletion | $1,090,000 | $1,009,000 | $1,054,000 | $1,015,000 |
| Depreciation And Amortization | $1,090,000 | $1,009,000 | $1,054,000 | $1,015,000 |
| Depreciation | $1,090,000 | $1,009,000 | $1,054,000 | $1,015,000 |
| Gain Loss On Investment Securities | $-825,000 | - | - | - |
| Net Income From Continuing Operations | $-35,574,000 | $-40,720,000 | $-44,238,000 | $-73,164,000 |
| Repayment Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-22